Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Hyoscine butylbromide

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    11 result(s) found for: Hyoscine butylbromide. Displaying page 1 of 1.
    EudraCT Number: 2022-000843-57 Sponsor Protocol Number: CRO22001 Start Date*: 2022-11-02
    Sponsor Name:RONTIS HELLAS S.A.
    Full Title: A double-blind, randomized, cross-over, multi-center efficacy and safety study of ibuprofen plus hyoscine butylbromide for pain management due to primary dysmenorrhea
    Medical condition: The efficacy and safety of ibuprofen plus hyoscine butylbromide for pain management due to primary dysmenorrhea will be investigated. Primary dysmenorrhea is the most common gynecological complaint...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-000779-26 Sponsor Protocol Number: ECABUSCA12 Start Date*: 2014-08-19
    Sponsor Name:Asociación Instituto Biodonostia
    Full Title: Efficacy of subcutaneous butylscopolamine vs placebo for control to death rattle in agony. Randomized clinical trial.
    Medical condition: phase of agony, pre-death
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-001921-19 Sponsor Protocol Number: BUSCAPART Start Date*: 2014-02-11
    Sponsor Name:Fundació Clínic per a la Recerca Biomèdica
    Full Title: Randomised, masked, placebo-controlled study to evaluate the effects of a single intravenous dose of hyoscine bromide on the duration and pain in the latent and active labor
    Medical condition: labor
    Disease: Version SOC Term Classification Code Term Level
    16.1 10036585 - Pregnancy, puerperium and perinatal conditions 10029767 Normal labour PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-005198-30 Sponsor Protocol Number: BBHV.02-2012 Start Date*: 2013-04-30
    Sponsor Name:LAURA TARRATS VELASCO
    Full Title: EFFICACY OF ADMINISTRATION OF HYOSCINE BUTILBROMIDE (BUSCOPAN®) ON PREGNANT WOMEN IN FIRST STAGE OF LABOUR IN CASE OF CERVIX RIGIDITY. (BBH V.04-2013 EUDRACT: 2012-005198-30)
    Medical condition: in case of cervix rigidity determination in first stage of labour, pregnant women will be offered to participate and if they accept they´ll be randomised to test or control group. Placebo or treat...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-004138-41 Sponsor Protocol Number: LPS16145 Start Date*: 2020-07-02
    Sponsor Name:Sanofi-Aventis Groupe
    Full Title: A phase IV randomized, double-blind, 3-treatment, 3-period, 6-sequence crossover clinical trial to assess the efficacy and safety of hyoscine butylbromide co-administered with ibuprofen compared to...
    Medical condition: Dysmenorrhoea
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10013935 Dysmenorrhoea PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-002966-39 Sponsor Protocol Number: STH13844 Start Date*: 2006-12-22
    Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust
    Full Title: A Double-blind randomised controlled trial to compare buscopan versus placebo as an adjunct to colonoscopy
    Medical condition: pathology of the large bowel as detected by colonoscopy
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-023643-15 Sponsor Protocol Number: BUSCOPAN_PDR1 Start Date*: 2011-01-18
    Sponsor Name:Deventer Hospital
    Full Title: The influence of hyoscine N-butylbromide on colonoscopic polyp detection ratio
    Medical condition: It is investigated whether the administration of Buscopan will improve the detection, removal and harvesting of colonic polyps during colonoscopy.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10010007 Colonoscopy LLT
    12.1 10010003 Colonic polyp LLT
    12.1 10010036 Colorectal carcinoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-002408-34 Sponsor Protocol Number: Nosponsor Start Date*: 2011-10-05
    Sponsor Name:Matti Ristikankare
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.0 10017947 - Gastrointestinal disorders 10000058 Abdominal crampy pains LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2006-005395-40 Sponsor Protocol Number: NSAP-01 Start Date*: 2007-05-03
    Sponsor Name:Barts and The London NHS Trust
    Full Title: Is Buscopan, paracetamol or a combination of both the most effective analgesia for the treatment of non-specific abdominal pain?
    Medical condition: Adult subjects attending the emergency department complaining of acute abdominal pain
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000081 Abdominal pain LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2016-002287-14 Sponsor Protocol Number: Reutelen Start Date*: 2016-12-23
    Sponsor Name:Erasmus MC Cancer Institute
    Full Title: Death rattle in the dying phase: is prophylactic treatment useful?
    Medical condition: Death rattle in the dying phase
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004855 10031920 Other diseases of trachea and bronchus, not elsewhere classified LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-005274-38 Sponsor Protocol Number: BRONSE Start Date*: 2016-03-10
    Sponsor Name:Region Östergötland
    Full Title: Patient-controlled sedation with propofol versus combined sedation during bronchoscopy – a randomized controlled trial
    Medical condition: Diagnostic bronchoscopy for referred outpatients
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 29 01:47:12 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA